Phenotypic heterogeneity in asthma and allergy

Clinical and Experimental Allergy, Supplement

Volumn 28, Issue 1, 1998, Pages 26-31

  Sandford, A J ^a   Weir, T D ^a   Pare P D ^a  

^a ST PAUL S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E;

ALLERGY; ASTHMA; ATOPY; BRONCHUS HYPERREACTIVITY; CONFERENCE PAPER; DISEASE ACTIVITY; ECZEMA; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENOTYPE; PHENOTYPE; PRIORITY JOURNAL; RHINITIS; SKIN TEST;

ASTHMA; GENETIC HETEROGENEITY; HUMANS; HYPERSENSITIVITY; MODELS, GENETIC; PHENOTYPE;

EID: 0031965989     PISSN: 09602178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (32)

1. Kendler KS. The impact of varying diagnostic thresholds on affected sib pair linkage analysis. Genet Epidemiol 1988; 5:407-19.
2. Cookson WOCM, Sharp PA, Faux JA, Hopkin JM. Linkage between immunoglobulin E responses underlying asthma and rhinitis and chromosome 11q. Lancet 1989; i:1292-5.
3. Marsh DG, Neely JD, Breazeale DR et al. Linkage analysis of IL4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations. Science 1994; 264:1152-6.
4. Meyers DA, Postma DS, Panhuysen CIM et al. Evidence for a locus regulating total serum IgE levels mapping to chromosome 5. Genomics 1994; 23:464-70.
5. Luoma R, Koivikko A. Occurrence of atopic diseases in three generations. Scand. J. Soc. Med. 1982; 10:49-56.
6. Barbee RA, Lebowitz MD, Thompson HC, Burrows B. Immediate skin-test reactivity in a general population sample. Ann. Int. Med. 1976;84:129-33.
7. Hanson B, McGue M, Roitman-Johnson B et al. Atopic disease and immunoglobulin E in twins reared apart and together. Am. J. Hum. Genet. 1991; 48:873-9.
8. Hopp RJ, Bewtra AK, Watt GD, Nair NM, Townley RG. Genetic analysis of allergic disease in twins. J Allergy Clin Immunol 1984; 73:265-70.
9. Marsh DG, Huang SK. Molecular genetics of human immune responsiveness to pollen allergens. Clin. Exp. Allergy 1991; 21 suppl 1:168-72.
10. Moffatt MF, Hill MR, Cornelis F et al. Genetic linkage of T-cell receptor α/δ complex to specific IgE responses. Lancet 1994; 343:1597-600.
11. Duffy DL, Martin NG, Battistutta D, Hopper JL, Mathews JD. Genetics of asthma and hay fever in Australian twins. Am. Rev. Respir. Dis. 1990; 142:1351-8.
12. Dold S, Wjst M, von Mutius E, Reitmeir P, Stiepel E. Genetic risk for asthma, allergic rhinitis, and atopic dermatitis. Arch. Dis. Child. 1992; 67:1018-22.
13. Duffy DL, Mitchell CA. Lower respiratory tract symptoms in Queensland schoolchildren: risk factors for wheeze, cough and diminished ventilatory function. Thorax 1993; 48:1021-4.
14. Mullarkey MF, Thomas PS, Hansen JA, Webb DR, Nisperos B. Association of aspirin-sensitive asthma with HLA-DQw2. Am. Rev. Respir. Dis. 1986; 133:261-3.
15. Bignon JS, Aron Y, Ju LY et al. HLA class II alleles in isocyanate-induced asthma. Am. J. Respir. Crit. Care Med 1994; 149:71-75.
16. Pirson F, Charpin D, Sansonetti M et al. Is intrinsic asthma a hereditary disease? Allergy 1991; 46:367-71.
17. Sibbald B, Turner Warick M. Factors influencing the prevalence of asthma among first degree relatives of extrinsic and intrinsic asthmatics. Thorax 1979; 34:322-37.
18. Marone G, Poto S, Celestino D, Bonini S. Human basophil releasability. III. Genetic control of human basophil releasability. J. Immunol. 1986; 137:3588-92.
19. Szefler S, Leung DY. Severe asthma. Pathogenesis and clinical management. Marcel Dekker Inc., New York. 1996.
20. Wamboldt MZ, Wamboldt FS. Psychosocial aspects of severe asthma in children. In Szefler S, Leung DY, eds Severe asthma. Pathogenesis and clinical management. Marcel Dekker Inc., New York. 1996:465-97.
21. Leung DYM. The glucocorticoid receptor as a target in the pathogenesis of steroid-resistant asthma. In Szefler S, Leung DYM, eds Severe asthma. Pathogenesis and clinical management. Marcel Dekker Inc., New York. 1996:285-313.
22. Lane SJ, Arm JP, Staynov DZ, Lee TH. Chemical mutational analysis of the human glucocorticoid receptor cDNA in glucocorticoid-resistant bronchial asthma. Am. J. Respir. Cell Mol. Biol. 1994; 11:42-8.
23. 2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry 1994; 33:9414-9.
24. 2-adrenergic receptor in normal and asthmatic subjects. Am. J. Respir. Cell Mol. Biol. 1993; 8:334-9.
25. 2-adrenergic receptor in nocturnal and nonnocturnal asthma. J. Clin. Invest. 1995; 95:1635-41.
26. 2-adrenoceptor polymorphism with lower airway reactivity in asthmatic subjects. Lancet 1995; 345:1213-4.
27. Moffatt MF, Cookson WOCM. Tumour necrosis factor haplotypes and asthma. Hum. Mol. Genet 1997; 6:551-4.
28. Rosenwasser LJ, Klemm DJ, Dresback JK et al. Promoter polymorphisms in the chromosome 5 gene cluster in asthma and atopy. Clin. Exp. Allergy 1995; 25 (Suppl.2):74-78.
29. Hill MR, Cookson WOCM. A new variant of the subunit of the high-affinity receptor for immunoglobulin E (Fε RI-β E237G): associations with measures of atopy and bronchial hyperresponsiveness. Hum. Mol. Genet. 1996; 5:959-62.
30. In KH, Asano K, Beier D et al. Naturally occurring mutations in the human 5- lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription. J Clin Invest 1997; 99:1130-7.
31. Benessiano J, Crestani B, Mestari F et al. High frequency of a deletion polymorphism of the angiotensin-converting enzyme gene in asthma. J. Allergy. Clin. Immunol. 1997; 99:53-7.
32. Stafforini DM, Satoh K, Atkinson DL et al. Platelet-activating factor acetylhydrolase deficiency. A missense mutation near the active site of an anti-inflammatory phospholipase. J. Clin. Invest. 1996; 97:2784-91.